Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 04, 2024

SELL
$26.13 - $33.94 $298,979 - $388,341
-11,442 Reduced 20.17%
45,290 $1.3 Million
Q3 2023

Oct 20, 2023

SELL
$32.09 - $37.51 $34,240 - $40,023
-1,067 Reduced 1.85%
56,732 $1.88 Million
Q2 2023

Jul 05, 2023

BUY
$36.12 - $41.79 $165,754 - $191,774
4,589 Added 8.62%
57,799 $2.12 Million
Q1 2023

Apr 04, 2023

BUY
$39.39 - $51.28 $26,745 - $34,819
679 Added 1.29%
53,210 $2.17 Million
Q4 2022

Jan 05, 2023

BUY
$41.75 - $54.5 $121,200 - $158,213
2,903 Added 5.85%
52,531 $0
Q3 2022

Oct 05, 2022

BUY
$43.76 - $53.42 $10,327 - $12,607
236 Added 0.48%
49,628 $2.17 Million
Q2 2022

Jul 05, 2022

BUY
$46.53 - $55.17 $70,725 - $83,858
1,520 Added 3.18%
49,392 $2.59 Million
Q1 2022

Apr 05, 2022

BUY
$45.75 - $56.69 $10,614 - $13,152
232 Added 0.49%
47,872 $2.48 Million
Q4 2021

Jan 04, 2022

SELL
$41.32 - $61.25 $27,601 - $40,915
-668 Reduced 1.38%
47,640 $2.81 Million
Q3 2021

Oct 08, 2021

BUY
$39.25 - $50.42 $60,759 - $78,050
1,548 Added 3.31%
48,308 $2.08 Million
Q2 2021

Jul 01, 2021

BUY
$35.91 - $40.68 $63,847 - $72,329
1,778 Added 3.95%
46,760 $1.83 Million
Q1 2021

Apr 05, 2021

BUY
$33.49 - $37.77 $138,715 - $156,443
4,142 Added 10.14%
44,982 $1.63 Million
Q4 2020

Jan 08, 2021

BUY
$33.47 - $42.56 $113,764 - $144,661
3,399 Added 9.08%
40,840 $1.5 Million
Q3 2020

Oct 01, 2020

BUY
$31.75 - $37.25 $285,210 - $334,616
8,983 Added 31.57%
37,441 $1.37 Million
Q2 2020

Jul 01, 2020

BUY
$30.12 - $36.54 $345,687 - $419,369
11,477 Added 67.59%
28,458 $931,000
Q1 2020

Apr 08, 2020

BUY
$27.03 - $38.62 $88,225 - $126,055
3,264 Added 23.8%
16,981 $554,000
Q4 2019

Jan 14, 2020

BUY
$32.92 - $37.36 $451,563 - $512,467
13,717 New
13,717 $537,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Modus Advisors, LLC Portfolio

Follow Modus Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Modus Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Modus Advisors, LLC with notifications on news.